Fintel reports that on November 21, 2025, BTIG reiterated coverage of Boston Scientific (NYSE:BSX) with a Buy recommendation.
Analyst Price Forecast Suggests 32.76% Upside
As of November 17, 2025, the average one-year price target for Boston Scientific is $128.25/share. The forecasts range from a low of $102.46 to a high of $147.00. The average price target represents an increase of 32.76% from its latest reported closing price of $96.60 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Boston Scientific is 14,925MM, a decrease of 22.86%. The projected annual non-GAAP EPS is 2.45.
What is the Fund Sentiment?
There are 2,905 funds or institutions reporting positions in Boston Scientific. This is an increase of 29 owner(s) or 1.01% in the last quarter. Average portfolio weight of all funds dedicated to BSX is 0.51%, an increase of 6.80%. Total shares owned by institutions decreased in the last three months by 0.82% to 1,540,573K shares. 
The put/call ratio of BSX is 0.72, indicating a bullish outlook.
What are Other Shareholders Doing?
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 47,576K shares representing 3.21% ownership of the company. In its prior filing, the firm reported owning 46,630K shares , representing an increase of 1.99%. The firm decreased its portfolio allocation in BSX by 3.08% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 41,994K shares representing 2.83% ownership of the company. In its prior filing, the firm reported owning 40,952K shares , representing an increase of 2.48%. The firm decreased its portfolio allocation in BSX by 3.00% over the last quarter.
Bank Of America holds 33,869K shares representing 2.28% ownership of the company. In its prior filing, the firm reported owning 33,845K shares , representing an increase of 0.07%. The firm decreased its portfolio allocation in BSX by 77.95% over the last quarter.
Primecap Management holds 33,102K shares representing 2.23% ownership of the company. In its prior filing, the firm reported owning 34,663K shares , representing a decrease of 4.71%. The firm decreased its portfolio allocation in BSX by 16.11% over the last quarter.
Geode Capital Management holds 32,691K shares representing 2.21% ownership of the company. In its prior filing, the firm reported owning 32,425K shares , representing an increase of 0.81%. The firm decreased its portfolio allocation in BSX by 55.69% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
